From mood trackers to guided cognitive-behavioral therapy (CBT) and peer support, depression apps are crowding the digital marketplace. As more patients turn to this technology to ease their symptoms, ...
High immune inflammation detected through simple blood tests is tied to a 57% higher risk of depression and a 56% higher risk ...
SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...
For decades, treating major depression has involved a frustrating cycle of trial and error, with patients cycling through ...
An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...
A new genetic and clinical analysis suggests that atypical depression represents a distinct biological subtype of the disorder with specific implications for treatment. The study found that ...